Yili Lactoferrin ShuHua Milk (Lactoferrin 5mg/100ml)
Dietary SupplementTotal 250mL milk (with lactoferrin 5mg/100ml) will be taken once per day at 10am daily during the 84 days intervention.
NCT Number: NCT01677702
The purpose of this study is to determine whether Yili Lactoferrin ShuHua Milk are effective in reducing the occurrence of flu symptoms.
Looking for future studies?
Notify Me6 year–75 year
All sexes
Interventional
Not applicable
NanMoFang Community Health Service Center, Chao Yang District, Beijing Municipality, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Total 250mL milk (with lactoferrin 5mg/100ml) will be taken once per day at 10am daily during the 84 days intervention.
Total 250mL milk (with lactoferrin 10mg/100ml) will be taken once per day at 10am daily during the 84 days intervention.
Total 250ml of placebo milk will be taken once a day at 10am daily during the 84 day intervention.
Time frame: 3 months
Time frame: 3 months
Time frame: 3 months
Time frame: Baseline & 3 months
Time frame: 3 months
Inner Mongolia Yili Industrial Group Co., Ltd
Industry
The Clinical Research on the Efficiency of Yili Lactoferrin Shuhua Milk in the Improvement of Human Immunization
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01677715
Abdominal Pain, Common Cold
ChaoYang District, Beijing Municipality, China
View Trial DetailsNCT02200276
Immunization, Infections
Baltimore, Maryland, United States
View Trial DetailsNCT06694025
Immunization, Infections
Seoul, Seoul-teukbyeolsi, South Korea
View Trial DetailsNCT04936776
Hematologic Diseases, Hemic and Lymphatic Diseases
New York, United States
View Trial Details